S. Brugnara

M‐CAM expression as marker of poor prognosis in epithelial ovarian cancer

D Aldovini, Francesca Demichelis, Claudio Doglioni et al. · International Journal of Cancer · 2006 · 87 citations

Medicine, Oncology, Pathology +17

Cisplatin, Dacarbazine With or Without Subcutaneous Interleukin-2, and Interferon Alfa-2b in Advanced Melanoma Outpatients: Results From an Italian Multicenter Phase III Randomized Clinical Trial

Ruggero Ridolfi, Vanna Chiarion‐Sileni, Michele Guida et al. · Journal of Clinical Oncology · 2002 · 71 citations

Medicine, Oncology, Pharmacology +17

Immune checkpoint inhibitor associated vitiligo and its impact on survival in patients with metastatic melanoma: an Italian Melanoma Intergroup study

Michele Guida, Sabino Strippoli, Milena Maule et al. · ESMO Open · 2021 · 57 citations · Full text

Medicine, Dermatology, Oncology +17

Central nervous system failure in melanoma patients: results of a randomised, multicentre phase 3 study of temozolomide- and dacarbazine- based regimens

Vanna Chiarion‐Sileni, Michele Guida, Laura Ridolfi et al. · British Journal of Cancer · 2011 · 55 citations · Full text

Medicine, Oncology, Pharmacology +14

Multiple Rechallenges for Castration-resistant Prostate Cancer Patients Responding to First-line Docetaxel: Assessment of Clinical Outcomes and Predictive Factors

Orazio Caffo, Giovanni Pappagallo, S. Brugnara et al. · Urology · 2012 · 53 citations

Medicine, Oncology, Urology +10